Academia Sinica joins U.S.-led cancer prevention project

Academia Sinica, Taiwan's top research institution, said Wednesday that it has joined a U.S.-initiated project that seeks cooperation among several countries in an effort to promote cancer prevention and control.

Earlier this year, Academia Sinica and Chang Gung University signed a new memorandum of understanding (MOU) with the National Cancer Institute in the United States to join the Cancer Moonshot initiative, which was announced in January. The MOU features a strategy of analyzing a large number of cancer cases and exploring the mechanism of when disease occurs.

Describing Academia Sinica as having leading proteogenomics technology, Chen Yu-ju (???), head of Academia Sinica's Institute of Chemistry, said that "this cooperation shows that Taiwan's proteogenomics technology has won international recognition and will help promote Taiwan's visibility in the area of academic research."

Academia Sinica and Chang Gung University signed MOUs with the National Cancer Institute in 2015 to develop international cooperation on using proteomic methods to characterize tumors and compare findings with other diagnostic features, including genomic characterization, according to Academia Sinica.

Earlier this year, the three organizations agreed to sign revised agreements to expand areas of cooperation, which makes Taiwan a participant in the U.S.-led cancer project, it said.

With the aim of accelerating the progress toward prevention, treatment and even a cure for cancer, President Barack Obama announced the Cancer Moonshot initiative in January and appointed Vice President Joe Biden to lead the effort.

During a recent speech at the 2016 Social Good Summit in New York, Biden expressed hope that by 2030, cancer will have disappeared from the world.

To achieve the goal, Biden announced steps through the Cancer Moonshot initiative, which include the announcement of new commitments with various countries to support better international cancer research and care.

The U.S. will work with institutions in Canada, China, Germany, Switzerland, Taiwan, Japan and South Korea in the field of proteogenomics, and with Serbia, Sweden and Japan to open a discussion about better prevention, screening, treatment and research collaboration, Biden said.

Meanwhile, the U.S. Department of Energy will work with Norway to share cervical screening data over the long term, he said.

The State Department will also strengthen U.S. bilateral science and technology engagements with other countries to support Cancer Moonshot, he added.

Source: Focus Taiwan News Channel